Webinar Invitation: Overcoming the Challenges in ADC Drug Product Development by Leveraging an Integrated Platform
As antibody-drug conjugates (ADCs) continue to evolve with increasingly diverse antibody, linker, and payload designs, drug product (DP) development has become more complex than ever. Achieving a robust and scalable DP strategy requires balancing formulation, stability, manufacturing, dosage form, and clinical administration while addressing the unique characteristics of each ADC molecule.
How can you overcome key drug product development challenges while accelerating development and ensuring product quality from early-stage development through commercialization?
Join our upcoming webinar to explore practical strategies, integrated platform capabilities, and real-world case studies that support successful ADC drug product development in a CDMO environment.
Key Learning Objectives
Common challenges in ADC drug product development
Strategies to mitigate light- and oxidation-induced degradation of ADCs
Optimization of lyophilized ADC drug product formulations
Customized in-use evaluations to support clinical administration
Speaker
Shujing Wang
Head of Drug Product Development, AsymBio
